The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease

Alzheimer’s Disease (AD) is the most common form of dementia, characterised by intra- and extracellular protein aggregation. In AD, the cellular protein quality control (PQC) system is derailed and fails to prevent the formation of these aggregates. Especially the mitochondrial paralogue of the cons...

Full description

Bibliographic Details
Main Authors: Françoise A. Dekker, Stefan G. D. Rüdiger
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.697913/full
_version_ 1818601065074917376
author Françoise A. Dekker
Françoise A. Dekker
Françoise A. Dekker
Stefan G. D. Rüdiger
Stefan G. D. Rüdiger
author_facet Françoise A. Dekker
Françoise A. Dekker
Françoise A. Dekker
Stefan G. D. Rüdiger
Stefan G. D. Rüdiger
author_sort Françoise A. Dekker
collection DOAJ
description Alzheimer’s Disease (AD) is the most common form of dementia, characterised by intra- and extracellular protein aggregation. In AD, the cellular protein quality control (PQC) system is derailed and fails to prevent the formation of these aggregates. Especially the mitochondrial paralogue of the conserved Hsp90 chaperone class, tumour necrosis factor receptor-associated protein 1 (TRAP1), is strongly downregulated in AD, more than other major PQC factors. Here, we review molecular mechanism and cellular function of TRAP1 and subsequently discuss possible links to AD. TRAP1 is an interesting paradigm for the Hsp90 family, as it chaperones proteins with vital cellular function, despite not being regulated by any of the co-chaperones that drive its cytosolic paralogues. TRAP1 encloses late folding intermediates in a non-active state. Thereby, it is involved in the assembly of the electron transport chain, and it favours the switch from oxidative phosphorylation to glycolysis. Another key function is that it ensures mitochondrial integrity by regulating the mitochondrial pore opening through Cyclophilin D. While it is still unclear whether TRAP1 itself is a driver or a passenger in AD, it might be a guide to identify key factors initiating neurodegeneration.
first_indexed 2024-12-16T12:45:27Z
format Article
id doaj.art-568cfcdb58bd43958ba0640481e44389
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-12-16T12:45:27Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-568cfcdb58bd43958ba0640481e443892022-12-21T22:31:19ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2021-06-01810.3389/fmolb.2021.697913697913The Mitochondrial Hsp90 TRAP1 and Alzheimer’s DiseaseFrançoise A. Dekker0Françoise A. Dekker1Françoise A. Dekker2Stefan G. D. Rüdiger3Stefan G. D. Rüdiger4Medicinal Chemistry, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, NetherlandsCellular Protein Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, NetherlandsScience for Life, Utrecht University, Utrecht, NetherlandsCellular Protein Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, NetherlandsScience for Life, Utrecht University, Utrecht, NetherlandsAlzheimer’s Disease (AD) is the most common form of dementia, characterised by intra- and extracellular protein aggregation. In AD, the cellular protein quality control (PQC) system is derailed and fails to prevent the formation of these aggregates. Especially the mitochondrial paralogue of the conserved Hsp90 chaperone class, tumour necrosis factor receptor-associated protein 1 (TRAP1), is strongly downregulated in AD, more than other major PQC factors. Here, we review molecular mechanism and cellular function of TRAP1 and subsequently discuss possible links to AD. TRAP1 is an interesting paradigm for the Hsp90 family, as it chaperones proteins with vital cellular function, despite not being regulated by any of the co-chaperones that drive its cytosolic paralogues. TRAP1 encloses late folding intermediates in a non-active state. Thereby, it is involved in the assembly of the electron transport chain, and it favours the switch from oxidative phosphorylation to glycolysis. Another key function is that it ensures mitochondrial integrity by regulating the mitochondrial pore opening through Cyclophilin D. While it is still unclear whether TRAP1 itself is a driver or a passenger in AD, it might be a guide to identify key factors initiating neurodegeneration.https://www.frontiersin.org/articles/10.3389/fmolb.2021.697913/fullprotein foldingproteostasismolecular chaperonesprotein quality controlprotein aggregationneurodegeneration
spellingShingle Françoise A. Dekker
Françoise A. Dekker
Françoise A. Dekker
Stefan G. D. Rüdiger
Stefan G. D. Rüdiger
The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
Frontiers in Molecular Biosciences
protein folding
proteostasis
molecular chaperones
protein quality control
protein aggregation
neurodegeneration
title The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
title_full The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
title_fullStr The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
title_full_unstemmed The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
title_short The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
title_sort mitochondrial hsp90 trap1 and alzheimer s disease
topic protein folding
proteostasis
molecular chaperones
protein quality control
protein aggregation
neurodegeneration
url https://www.frontiersin.org/articles/10.3389/fmolb.2021.697913/full
work_keys_str_mv AT francoiseadekker themitochondrialhsp90trap1andalzheimersdisease
AT francoiseadekker themitochondrialhsp90trap1andalzheimersdisease
AT francoiseadekker themitochondrialhsp90trap1andalzheimersdisease
AT stefangdrudiger themitochondrialhsp90trap1andalzheimersdisease
AT stefangdrudiger themitochondrialhsp90trap1andalzheimersdisease
AT francoiseadekker mitochondrialhsp90trap1andalzheimersdisease
AT francoiseadekker mitochondrialhsp90trap1andalzheimersdisease
AT francoiseadekker mitochondrialhsp90trap1andalzheimersdisease
AT stefangdrudiger mitochondrialhsp90trap1andalzheimersdisease
AT stefangdrudiger mitochondrialhsp90trap1andalzheimersdisease